Your browser doesn't support javascript.
loading
Stepwise strategy for generating osteoblasts from human pluripotent stem cells under fully defined xeno-free conditions with small-molecule inducers.
Zujur, Denise; Kanke, Kosuke; Onodera, Shoko; Tani, Shoichiro; Lai, Jenny; Azuma, Toshifumi; Xin, Xiaonan; Lichtler, Alexander C; Rowe, David W; Saito, Taku; Tanaka, Sakae; Masaki, Hideki; Nakauchi, Hiromitsu; Chung, Ung-Il; Hojo, Hironori; Ohba, Shinsuke.
Afiliação
  • Zujur D; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Kanke K; Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Onodera S; Department of Biochemistry, Tokyo Dental College, Tokyo, Japan.
  • Tani S; Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Lai J; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Azuma T; Department of Biochemistry, Tokyo Dental College, Tokyo, Japan.
  • Xin X; Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
  • Lichtler AC; Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
  • Rowe DW; Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
  • Saito T; Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tanaka S; Department of Sensory and Motor System Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Masaki H; Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakauchi H; Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Chung UI; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Hojo H; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.
  • Ohba S; Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Regen Ther ; 14: 19-31, 2020 Jun.
Article em En | MEDLINE | ID: mdl-31988991
ABSTRACT
Clinically relevant human induced pluripotent stem cell (hiPSC) derivatives require efficient protocols to differentiate hiPSCs into specific lineages. Here we developed a fully defined xeno-free strategy to direct hiPSCs toward osteoblasts within 21 days. The strategy successfully achieved the osteogenic induction of four independently derived hiPSC lines by a sequential use of combinations of small-molecule inducers. The induction first generated mesodermal cells, which subsequently recapitulated the developmental expression pattern of major osteoblast genes and proteins. Importantly, Col2.3-Cherry hiPSCs subjected to this strategy strongly expressed the cherry fluorescence that has been observed in bone-forming osteoblasts in vivo. Moreover, the protocol combined with a three-dimensional (3D) scaffold was suitable for the generation of a xeno-free 3D osteogenic system. Thus, our strategy offers a platform with significant advantages for bone biology studies and it will also contribute to clinical applications of hiPSCs to skeletal regenerative medicine.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article